Same gut bacteria linked to belly fat in 1,771 people, confirmed in mice

If you have ever wondered why fat around your middle seems to have a mind of its own, a new gut microbiome study offers one concrete answer: the bacteria living in your intestines may be steering part of the process. Researchers screened more than seventeen hundred healthy adults for the microbes most tied to visceral fat, the deep abdominal fat that wraps around the liver and other organs, then tested their top two suspects directly in mice. The result is something this field rarely produces: a specific bacterial cause, not just a statistical association.

Key takeaways

• In a cohort of 1,771 healthy South Koreans, two gut bacteria species, Dorea longicatena and Bifidobacterium adolescentis, showed the strongest ties to visceral fat and a broader obesity score.
• When researchers gave these same bacteria to mice by mouth, the mice gained significantly more body weight and fat mass than untreated mice on the identical diet, turning a correlation into a demonstrated cause.
• The bacteria were tied to a microbial pathway called glycogen synthesis (how cells build and store a form of sugar), alongside upregulated fat-storage genes in the mice's livers.
• Caveat: this is not proof that a probiotic supplement causes weight gain, prior research on B. adolescentis specifically has found conflicting effects, and the human portion of the study is observational, not causal.

Two Gut Bacteria Species Tied to Visceral Fat

Two specific bacteria, Dorea longicatena and Bifidobacterium adolescentis, are the strongest gut microbial signatures linked to visceral fat in a new study of healthy adults, published in Experimental & Molecular Medicine, a Nature-family journal. Researchers analyzed stool samples from 1,771 healthy Koreans (narrowed down from an initial 1,833 volunteers after excluding those with incomplete health records) using 16S rRNA sequencing, a method that identifies bacteria by reading one shared piece of their DNA. Out of 52 clinical variables measured, visceral fat, more than BMI, waist circumference, or total body fat, showed the most consistent ties to the makeup of a person's gut bacteria. A follow-up shotgun metagenomic analysis (a deeper sequencing method that reads nearly all the DNA in a sample rather than one marker gene) on a subset of 44 participants pointed to Dorea longicatena and Bifidobacterium adolescentis as the two species most consistently correlated with visceral fat, total fat, waist circumference, and a composite obesity score built from nine separate clinical measurements.

Why Visceral Fat Outranks BMI as a Health Signal

Visceral fat matters more to long-term health than a number on a bathroom scale because it behaves almost like its own hormone-producing organ, driving inflammation and metabolic disease even in people whose overall weight looks unremarkable. It secretes pro-inflammatory signals and free fatty acids that promote insulin resistance, and the study's authors note it is closely tied to type 2 diabetes, elevated triglycerides, and cardiovascular disease. That distinction matters for anyone managing prediabetes, metabolic syndrome, or fatty liver concerns, since two people with the same BMI can carry very different amounts of this deeper, more dangerous fat, and this study suggests gut bacteria composition may help explain why.

How Researchers Moved From Human Data to Mouse Proof

The methodological move that makes this study credible is pairing a large human cohort with a controlled causation test in mice, something most microbiome-obesity research still lacks. After identifying Dorea longicatena and Bifidobacterium adolescentis as candidates in the human data, the researchers depleted the existing gut bacteria in six-week-old male mice with a one-week course of antibiotics, then fed the mice a high-fat diet while dosing them daily, by mouth, with 100 million colony-forming units of one of the two bacteria (groups of 14 to 15 mice each, versus a control group given a saline solution). Starting around week three to four, both treated groups gained significantly more body weight than the control mice. In the Dorea longicatena group, body scans confirmed the extra weight was fat, not muscle, with measurably heavier fat pads around the organs, and both bacteria raised the mice's blood leptin (a hormone that signals body fat levels) and liver weight compared to controls.

What This Means If You're Watching Your Metabolic Health

For someone already concerned about insulin resistance, prediabetes, or fatty liver, this study is a reason to keep an eye on visceral fat specifically, not just weight or BMI, when discussing metabolic risk with a doctor. It is not, however, a reason to seek out or avoid a Bifidobacterium probiotic: the study tested one specific strain colonizing the gut long-term in a controlled experiment, not an over-the-counter supplement, and the researchers themselves note that a probiotic pill and a colonizing gut resident are not the same exposure. Nothing here has been tested as a treatment in people, and the authors describe this as groundwork for future personalized approaches, not a validated intervention.

The Open Questions This Study Doesn't Answer

The clearest limitation, flagged by the authors themselves, is that the link between the bacteria's own glycogen-synthesis activity and the fat-storage genes it switched on in mouse livers is an association between two independent findings, not a proven step-by-step mechanism; they explicitly call for future studies measuring bacterial glycogen directly in the gut. The prior literature on Bifidobacterium adolescentis is also genuinely mixed: some earlier mouse studies found it reduces visceral fat rather than adding it, and the new authors acknowledge there is no scientific consensus on this species and obesity. Finally, every human participant was healthy at enrollment, so the findings say nothing yet about people who already have metabolic syndrome or type 2 diabetes.

What Comes Next for Microbiome-Based Obesity Research

The research team says the clearest next step is measuring bacterial glycogen directly inside the gut (in stool or intestinal samples) rather than inferring it from genetic sequencing data, to nail down the mechanism linking bacterial glycogen synthesis to host fat storage. They also call for extending the work to people who already have metabolic syndrome, since this cohort included only healthy volunteers. No clinical timeline was given for any of this, and the authors are explicit that none of it is ready for clinical use yet.

Common Questions

Does taking a Bifidobacterium probiotic cause weight gain? No. This study colonized mice long-term with a single wild strain in a controlled lab setting, not a store-bought supplement, and earlier research on the same species has found it can also reduce visceral fat in other models, so the effect is not settled either way.

Is this proven in humans or only in mice? The bacteria-to-visceral-fat link was observed in 1,771 South Korean adults, but the actual cause-and-effect proof, watching weight and fat gain happen after dosing with the bacteria, was demonstrated only in mice so far.

What is the glycogen synthesis pathway mentioned in the study? It is a set of bacterial genes that convert sugar into glycogen (a storage form of glucose); the researchers found this pathway was unusually active in people with more visceral fat and propose it may push surplus energy toward fat storage rather than being burned.

Are these bacteria unique to Korean populations? No. Dorea longicatena appears on both the Korean and a published North American reference list of common gut species, which the authors say points to global relevance rather than a finding specific to one population's diet or genetics.

References

1. Nam-Eun Kim, Beomki Cho, Yunjae Kim, et al. (2026). Linking visceral fat accumulation to gut microbiota: key bacterial taxa and their roles in the glycogen synthesis pathway. Experimental & Molecular Medicine. https://doi.org/10.1038/s12276-026-01828-7
2. Gut microbiota in obesity. NIH. https://pmc.ncbi.nlm.nih.gov/articles/PMC8291023/
3. Majid Iqbal, Qian Yu, Jingqun Tang, Juanjuan Xiang (2025). Unraveling the gut microbiota’s role in obesity: key metabolites, microbial species, and therapeutic insights. Journal of Bacteriology. https://doi.org/10.1128/jb.00479-24